Stop Smoking News Clip

Swiss Strategy A.G. to Launch Switzerland’s First Smoke-Free Cigarette – NicStic

 

Swiss Strategy A.G. to Launch Switzerland’s First Smoke-Free Cigarette – NicStic  

Zurich, Switzerland - Swiss Strategy Aktiengesellschaft proudly announces the introduction of Switzerland's first smoke-free cigarette, NicStic. Following an evaluation by the Swiss Medicines Institute, Swissmedic, the product has been determined not to fall under the scope of medicines law. This milestone paves the way for NicStic to be produced and sold in the Swiss market.  

NicStic is an innovative product designed to provide nicotine in a cigarette-like manner without exposing users or bystanders to harmful tobacco smoke. As global smoking bans and restrictions become increasingly prevalent, NicStic offers a revolutionary solution for nicotine-dependent smokers who face significant physical and psychological challenges due to these regulations.  

With product development completed, series production is slated to begin this fall. The product has already garnered substantial interest, with widespread anticipation for its launch both in Switzerland and internationally.  

To support the global market rollout, Swiss Strategy A.G. is actively engaging with private and institutional investors, alongside potential licensees across Europe and overseas.  

"We are thrilled to introduce this groundbreaking product to address the needs of nicotine-dependent smokers worldwide," said Marina Krueger, Ph.D., Chief Medical Officer of Swiss Strategy Aktiengesellschaft. "NicStic represents a safe, innovative, and practical alternative to conventional smoking, aligning with evolving health and regulatory landscapes." 

About Swiss Strategy A.G.

  

Swiss Strategy A.G. is a Swiss marketing firm dedicated to promoting science-based innovations that benefit the economy and society. The company facilitates partnerships between visionary scientists and the Swiss market, bringing patented inventions and inspiring solutions to life. Swiss Strategy A.G. champions Swiss start-ups and innovative products that shape the future.  

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.  

For more information about NicStic, please visit: https://demo6429d4d7979f7.yolasitebuilder.loopia.com 

Investor Relations:

  

Marina Krueger, Ph.D.  

Chief Medical Officer  

Swiss Strategy Aktiengesellschaft  

Schützenmattstrasse 71  

CH-8180 Bülach, Switzerland  

Tel: +41 79 123 57-84  

Email: news@nicstic.eml.monster  

Blog: https://nicsticag.blogspot.com  

Photo Caption: Thomas Schroepfer presenting NicStic on WSVN-TV South Florida's News Station.  

SOURCE: Swiss Strategy A.G.

YouTube Link: https://www.youtube.com/watch?v=bEyHr--_UJI

The financial future of NicStic appears promising, driven by its unique positioning as a smoke-free cigarette in a global market increasingly focused on health-conscious solutions and stricter smoking regulations. With production slated to begin soon and significant interest from investors and licensees across Europe and overseas, NicStic is poised to capitalize on a growing demand for alternatives to traditional smoking. Its innovative approach not only broadens the customer base but also opens opportunities for strategic partnerships and licensing agreements. As awareness and adoption increase, NicStic has the potential to establish a strong foothold in the multi-billion-dollar nicotine alternatives market, paving the way for sustained growth and profitability.